FACT-CHECK
Why Samchundang Pharm Fell 14.6% While KOSDAQ Rose 2%
Samchundang Pharm fell 14.56% as KOSDAQ rose. No filing explains it; a press report cites a U.S. approval delay.
1 article(s) on Korean Biosimilars stocks, checked against filings and numbers.
Samchundang Pharm fell 14.56% as KOSDAQ rose. No filing explains it; a press report cites a U.S. approval delay.